Drug delivery systems based on sugar-macromolecule conjugates

Current Opinion in Drug Discovery and Development

Volumn 5, Issue 2, 2002, Pages 279-288

  Davis, Benjamin G ^a   Robinson, Mark A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Glycoconjugate; Glycoprotein; Glycotargeting; Lectin; Oligosaccharides; Receptor mediated endocytosis

Indexed keywords

CARBOHYDRATE; GLYCOCONJUGATE; POLYAMINOACID; PROTEIN; SUGAR;

DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STRUCTURE; ENDOCYTOSIS; LIGAND BINDING; MACROMOLECULE; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; REVIEW;

ANIMALS; CARBOHYDRATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MACROMOLECULAR SUBSTANCES; PEPTIDES; POLYSACCHARIDES; PROTEINS;

EID: 0036489778     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Hepatic uptake of proteins coupled to fetuin glycopeptide
2. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes
3. Receptor-mediated glycotargeting
4. Receptor-mediated delivery of foreign genes to hepatocytes
5. Cell-specific delivery of genes with glycosylated carriers
6. Receptor-mediated targeted drug or toxin delivery
7. Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
8. Endogenous lectins as targets for drug delivery
9. Asialoglycoprotein receptor in human isolated hepatocytes from normal liver and its apparent increase in liver with histological alterations
10. Endogenous lectins and neoglycoconjugates: A sweet approach to tumour diagnosis and targeted drug delivery
11. Glycotargeting: Influence of the sugar moiety on both the uptake and the intracellular trafficking of nucleic acid carried by glycosylated polymers
12. Recent developments in glycoconjugates
13. Glycopeptide synthesis and the effects of glycosylation on protein structure and activity
14. Synthesis of glycoproteins
15. Glycotargeting: The preparation of glyco-amino acids and derivatives from unprotected reducing sugars
16. Development of gene drug delivery systems based on pharmacokinetic studies
17. Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional α2,3/α2,6 sialylation: Synthesis of neoglycoproteins and their properties in lectin assays, cell binding and organ uptake
18. In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein
19. Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation
20. Characerization of a novel kidney-specific delivery system using an alkylglucoside vector
21. Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins
22. Lectin-mediated drug targeting: Discrimination of carbohydrate-mediated cellular uptake between tumor and liver cells with neoglycoconjugates carrying fucose epitopes regioselectively modified in the 3-position
23. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: A possible carrier for Kupffer cells
24. Design of polymeric prodrugs of prostaglandin E-1 having galactose residue for hepatocyte targeting
25. Synthesis and pharmacological activity of a novel water-soluble hepatocyte-specific polymeric prodrug of prostaglandin E-1 using lactosylated poly(L-glutamic hydrazide) as a carrier
26. Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting
27. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice
28. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
29. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells
30. Further studies on the site-specific protein modification by microbial transglutaminase
31. Enzymic synthesis of neoglycopeptide building blocks
32. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives
33. Targeted delivery and improved therapeutic potential of catalase by chemical modification: Combination with superoxide dismutase derivatives
34. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon
35. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived β-glucocerebrosidase: Implications for clinical efficacy in treatment of Gaucher disease
36. Evidence for receptor-mediated hepatic uptake of pullulan in rats
37. Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats
38. Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice
39. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier
40. Liver cell specific targeting of peptide nucleic acid oligomers
41. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo
42. Conjugation of plasmid DNAs with lactose via diazocoupling enhances resistance to restriction enzymes and acquires binding affinity to galactose-specific lectin
43. Facile synthesis of stable and lectin-recognizable DNA-carbohydrate conjugates via diazo coupling
44. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine
45. Phase I trial of liver targeted HPMA copolymer of doxorubicin PK2, pharmacokinetics, SPECT imaging of 1-123-PK2 and activity in hepatoma
46. Preclinical evaluation of the cardiotoxicity of PK2. A novel HPMA copolymer-doxorubicin-galactosamine conjugate antitumour agent
47. Enhanced-biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells
48. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene
49. Specific binding of glucose-derivatized polymers to the asialoglycoprotein receptor of mouse primary hepatocytes
50. Synthesis of galactosyl compounds for targeted gene delivery
51. Preparation and characterization of neoglycoprotein-liposome conjugates: A promising approach to developing drug delivery materials applying sugar chain ligands
52. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells
53. Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor
54. Modification of the plasma clearance and liver uptake of steroid ester-conjugated oligodeoxynucleotides by association with (lactosylated) low-density lipoprotein
55. Carrier-mediated delivery of 9-(2-phosphonylmethoxy-ethyl)adenine to parenchymal liver cells: A novel therapeutic approach for hepatitis B
56. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs
57. Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLeX, in a mouse mammary adenocarcinoma model
58. In vitro gene transfer with a novel galactosylated spermine bolaamphiphile
59. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes
60. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo
61. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting
62. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers
63. Carbohydrates in medicine
64. Hand in Glove
65. Emerging themes in medicinal glycoscience
66. Lectin-mediated mucosal delivery of drugs and microparticles